Quarterly report pursuant to Section 13 or 15(d)

Basic and Diluted Net Loss Per Share (Tables)

v3.19.3
Basic and Diluted Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2019
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Net Loss Per Share

The following table sets forth the computation of the Company’s basic and diluted net loss per share for:

 

    Three-months ended September 30, 2019 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (1,433,626 )     136,640,761     $ (0.01 )
Effect of dilutive securities—Common stock options, warrants, and convertible note     -       -       -  
Diluted loss per share   $ (1,433,626 )     136,640,761     $ (0.01 )

 

    Three-months ended September 30, 2018 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (928,888 )     130,083,598     $ (0.01 )
Effect of dilutive securities—Common stock options, warrants, and convertible note     -       -       -  
Diluted loss per share   $ (928,888 )     130,083,598     $ (0.01 )

 

    Nine-months ended September 30, 2019 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (3,650,740 )     135,516,490       (0.03 )
Effect of dilutive securities—Common stock options, warrants, and convertible note     -       -       -  
Diluted loss per share   $ (3,650,740 )     135,516,490       (0.03 )

 

    Nine-months ended September 30, 2018 (Unaudited)  
    Net Loss (Numerator)     Shares (Denominator)     Per share
amount
 
Basic loss per share   $ (3,076,873 )     125,271,516     $ (0.02 )
Effect of dilutive securities—Common stock options, warrants, and convertible note     -       -       -  
Diluted loss per share   $ 3,076,873       125,271,516     $ (0.02 )

Schedule of Shares of Common Stock Equivalents Were Excluded from the Computation of Diluted Net Loss Per Share

The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been antidilutive for the periods ended:

 

    September 30, 2019     September 30, 2018  
    (Unaudited)     (Unaudited)  
Convertible notes     9,490,186       -  
Common stock options     40,438,425       39,496,761  
Common stock warrants     102,758,031       118,148,846  
Total common stock equivalents     152,686,642       157,645,607